Press Release: Neoventa Introduces the STAN S41, Fetal Heart Monitor

Mölndal, Sweden – May 23, 2017: Scandinavian medtech pioneers, Neoventa, today announced their new STAN S41, Fetal Heart Monitor.

The STAN S41 was developed in collaboration with Sunray Medical Apparatus Co., Ltd, and is the only CTG (cardiotocograph) monitor in the world that incorporates ST Analysis.

ST Analysis is an evidence based method that gives you a continuous and central message from the fetal heart during labour. “It is a great support for the obstetric staff and provides, ‘a second pair of eyes’,” says Ulf Järnberg, CEO of Neoventa. The evidence has shown, by applying ST Analysis as an adjunct to CTG, results in significantly fewer babies born with oxygen deficiency, and a reduction in operative deliveries. Observational studies have also shown a reduction in the rate of C-sections.”

A Strategic Partnership
For the past two years, Neoventa has been collaborating with Sunray Medical Apparatus Co., Ltd; one of the world’s foremost providers of fetal monitors, represented in over 10,000 hospitals throughout the world. The partnership combines Sunray’s expertise in CTG monitors with Neoventa’s patented STAN technology to add ST Analysis for today’s increasing demands in obstetric care.

“We are happy to have teamed up with one of the most respected names in obstetrics and gynaecology. This mutual partnership has opened new possibilities in the field of obstetric care,” says Dan Pitulia, Chairman of the Board at Neoventa. “Because of this collaboration, we can now offer ST Analysis with new and unique technical features.”

Great Today, Brilliant for the Future
The STAN S41 is designed to support many different configurations which makes it easy to adapt to the workflow. Featured highlights:

  • ST Analysis of the fetal ECG – a message from the fetal heart
  • Integrated telemetry monitoring – for ease of use and portability
  • Large coloured touch screen – for convenient access to interpret traces and values
  • Triplet Ultrasound FHR – multiple monitoring capacity
  • Neoventa Academy – comprehensive education provided

Launch – STAN S41
The launch for the STAN S41 will be held at the 3rd European Congress on Intrapartum Care, 25-27th of May in Stockholm, at Karolinska Institutet.

 

Press Contact: Ulf Järnberg, CEO
Neoventa Medical AB
Phone +46 31 758 32 00
info@neoventa.com

About

Neoventa Medical AB is a Swedish medical device company founded in 1997 providing innovative fetal monitoring solutions and services that improve obstetric care. Everyday, in obstetric centres across the globe, health care professionals use Neoventa’s unique solutions to ensure a good start in life.

Neoventa. “It’s All In The Beat”

Sunray Medical Apparatus Co., Ltd was founded in 1992, dedicated to the field of OB/GYN areas, with a mission to improve the health of fetuses and women. Sunray has established its R&D and manufacture center in the heart of Guangzhou city and offers a wide range of products, including fetal monitors, fetal dopplers, and patient monitors.

© 2017 Neoventa Medical AB. All rights reserved. STAN, Goldtrace, and the STAN baby logo are trademarks of Neoventa. Other company and product names may be trademarks of their respective owners.

# #